Diebold Nixdorf Inc(DBD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 21.36 | EPS (ttm) | 3.06 | Insider Own | 1.96% | Shs Outstand | 34.0M | Perf Week | -3.49% |
| Market Cap | 2.22B | Forward P/E | 9.3 | EPS next Y | 30.65% | Insider Trans | -62.49% | Shs Float | 33.3M | Perf Month | -7.82% |
| Enterprise Value | 3.05B | PEG | - | EPS next Q | 1.31 | Inst Own | 135.71% | Short Float | 8.79% | Perf Quarter | -19.21% |
| Income | 0.11B | P/S | 0.57 | EPS this Y | -3.88% | Inst Trans | 14.33% | Short Ratio | 9.92 | Perf Half Y | -13.2% |
| Sales | 3.87B | P/B | 2.29 | EPS next 5Y | - | ROA | 2.97% | Short Interest | 2.92M | Perf YTD | -3.86% |
| Book/sh | 28.5 | P/C | 7.85 | EPS past 3/5Y | - | ROE | 10.76% | 52W High | -29.12% ($92.08) | Perf Year | 9.59% |
| Cash/sh | 8.32 | P/FCF | 9.31 | Sales past 3/5Y | 3.22% -0.49% | ROIC | 5.5% | 52W Low | 19.81% ($54.48) | Perf 3Y | 265.45% |
| Dividend Est. | - | EV/EBITDA | 6.45 | EPS Y/Y TTM | 1014.16% | Gross Margin | 26.28% | Volatility(W/M) | 3.29% 3.2% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 0.79 | Sales Y/Y TTM | 5.44% | Oper. Margin | 9% | ATR (14) | 2.43 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.83 | EPS Q/Q | 34.98% | Profit Margin | 2.87% | RSI (14) | 33.18 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.27 | Sales Q/Q | 1.7% | SMA20 | -4.43% ($68.3) | Beta | 1.16 | Target Price | $98.33 |
| Payout | - | Debt/Eq | 1.14 | Earnings | 2026/7/29 | SMA50 | -14.47% ($76.31) | Rel Volume | 0.58 | Prev Close | $66.48 |
| Employees | 20000 | LT Debt/Eq | 1.09 | EPS/Sales Surpr. | -0.3% 0.49% | SMA200 | -13.46% ($75.42) | Avg Volume(3M) | 0.29M | Price | $65.27 |
| IPO | 2023/8/14 | Option/Short | Yes/Yes | Trades | 4949 | Volume | 171,988 | Change | -1.82% |
Company
DBD is a Technology sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
This is a U.S. technology company that provides financial and retail automation technologies. It offers automation hardware such as ATMs, self-checkout systems, and point-of-sale terminals, along with related software and services, giving it exposure to demand for banking and retail automation. The company operates in the financial and retail automation sector.
Over the past 1 year, roughly in the middle
29% below its 1-year high.
DBD earns at a steady pace
9% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -3.9% this year.
Tap to view numbers
The stock looks undervalued
Trading at 21.4 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Long-term returns are close to the market
Would have changed by +265.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 135.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $2B.
FAQ
What kind of company is DBD?
DBD belongs to the Technology sector and operates in the Software - Application industry.
What is the market cap of DBD?
The market cap of DBD is approximately $2.2B, ranking 2,014 within its sector.
What is the P/E ratio of DBD?
DBD has a P/E ratio of approximately 21.4x, which can be used to assess its valuation relative to the Technology sector average.
What is the 52-week high and low for DBD?
DBD has recorded a 52-week high of $92.08 and a low of $54.48.